|
2022
|
Invention
|
Pharmaceutical composition comprising trans - cinnamaldehyde and its use in the treatment of infe... |
|
2017
|
Invention
|
Potentiated tulathromycin. The invention relates to enhanced tulathromycin for use in the treatme... |
|
|
Invention
|
Enhanced tulathromycin. The invention relates to enhanced tulathromycin for use in the treatment,... |
|
2016
|
Invention
|
Anti-microbial composition. This invention pertains to an anti-microbial, in particular anti-bact... |
|
|
Invention
|
Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infect... |
|
2015
|
Invention
|
Potentiated antimicrobial agents. The object of the invention is to provide a potentiated antimic... |
|
|
Invention
|
Potentiated antimicrobial agents. The invention relates to a potentiated antimicrobial agent for ... |
|
2010
|
Invention
|
Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of b... |
